Ekso Bionics Holdings, Inc. has announced a reverse stock split at a 1-for-15 ratio, effective June 2, 2025. This adjustment will reduce the number of outstanding shares from approximately 35.5 million to 2.4 million. The move aims to increase the per share trading price of Ekso Bionics' common stock. The stock will continue to trade under the symbol "EKSO" on Nasdaq, with a new CUSIP number 282644 400. The decision was approved by the company's stockholders on May 16, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.